Essential Partners
PROK icon

Essential Partners’s ProKidney PROK Stock Holding History

Essential Partners’s Portfolio PROK Stock Details PROK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$40 Buy
+24
New +$40 ﹤0.01% 2783
2025
Q3 		– Sell
-528
Closed -$313 – 2760
2025
Q2 		$313 Buy
+528
New +$411 ﹤0.01% 1829

Other funds holding PROK

Hennion & Walsh Asset Management
Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return
Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
Aaron Wealth Advisors
Aaron Wealth Advisors Chicago, Illinois $2.04B AUM 32.69% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
SignatureFD
SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

Essential Partners's PROK Position: Q3 2026 in Review

Essential Partners opened a new position in ProKidney (PROK) in Q3 2026: 24 shares worth $40. The stake represents ﹤0.01% of the portfolio and ranks #2783 among its holdings. This is a return to the name: Essential Partners previously reported a position in PROK as recently as Q2 2025.

Essential Partners first reported a position in PROK in Q2 2025 and has held it in 2 quarters since. The position peaked at $313 in Q2 2025. 12 funds tracked by Wall St. Rank hold PROK as of Q3 2026.

  • Essential Partners held 24 shares of ProKidney worth $40 as of Q3 2026.
  • ProKidney was a new Essential Partners position in Q3 2026.
  • ProKidney made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2783 holding.
  • Essential Partners first reported a position in ProKidney in Q2 2025 and has held it in 2 quarters since.
  • Essential Partners's ProKidney position peaked at $313 in Q2 2025.
  • 12 funds tracked by Wall St. Rank held ProKidney as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.